71
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings

, , , , , & show all
Pages 1883-1893 | Accepted 01 Oct 2004, Published online: 28 Oct 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Thomas R. Einarson, Basil G. Bereza, Fadi Tedouri, Kristel Van Impe, Tom R. Denee & Pieter J. T. Dries. (2017) Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands. Journal of Medical Economics 20:11, pages 1187-1199.
Read now
Stanley Victor Catts, Aaron Desmond James Frost, Shaune Gifford & James Scott. (2008) Real-world use of quetiapine in early psychosis: An acute inpatient and community follow-up effectiveness study. International Journal of Psychiatry in Clinical Practice 12:1, pages 65-73.
Read now
Robert J. Valuck, Elaine H. Morrato, Sheri Dodd, Gary Oderda, Dean G. Haxby & Richard Allen. (2007) How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs. Current Medical Research and Opinion 23:10, pages 2567-2576.
Read now

Articles from other publishers (4)

Trevor C. Chopko & Craig W. Lindsley. (2018) Classics in Chemical Neuroscience: Risperidone. ACS Chemical Neuroscience 9:7, pages 1520-1529.
Crossref
Sebastian Braun, Jan Zeidler, Thomas Mittendorf & J. -Matthias Graf von der Schulenburg. (2013) Kosteneffektivität von Quetiapin und Haloperidol bei Patienten mit partiell therapieresistenter SchizophrenieCost-effectiveness analysis of quetiapine and haloperidol for partial responders in schizophrenia. PharmacoEconomics German Research Articles 8:1, pages 21-29.
Crossref
David R. Strutton, Benjamin Gutierrez & Christopher M . Blanchette. (2008) Influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia. American Journal of Health-System Pharmacy 65:1, pages 42-48.
Crossref
Jason M. Noel. (2007) ASHP Therapeutic Position Statement on the Use of Second-Generation Antipsychotic Medications in the Treatment of Adults with Psychotic Disorders. American Journal of Health-System Pharmacy 64:8, pages 863-876.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.